Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Analysis Reveals the Biomarker Value and Potential Mechanism of miR-675-3p in Gastric Cancer. | Comput Intell Neurosci | 2022 | 35814566 | PubTator, text mining | PubMed |
| Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis. | ACS Omega | 2022 | 35811900 | PubTator, text mining | PubMed |
| LncRNA-Mediated Adipogenesis in Different Adipocytes. | Int J Mol Sci | 2022 | 35806493 | PubTator, text mining | PubMed |
| Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification. | Int J Mol Sci | 2022 | 35805978 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma. | Evid Based Complement Alternat Med | 2022 | 35795287 | PubTator, text mining | PubMed |
| Miscarriage syndrome: Linking early pregnancy loss to obstetric and age-related disorders. | EBioMedicine | 2022 | 35779492 | PubTator, text mining | PubMed |
| Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects. | Mater Today Bio | 2022 | 35774196 | PubTator, text mining | PubMed |
| Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid. | Burns Trauma | 2022 | 35769828 | PubTator, text mining | PubMed |
| Comparative analysis of transient receptor potential channel 5 opposite strand-induced gene expression patterns and protein-protein interactions in triple-negative breast cancer. | Oncol Lett | 2022 | 35765270 | PubTator, text mining | PubMed |
| Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential. | Oxid Med Cell Longev | 2022 | 35757505 | PubTator, text mining | PubMed |
| Application of Induced Pluripotent Stem Cell-Derived Models for Investigating microRNA Regulation in Developmental Processes. | Front Genet | 2022 | 35719367 | PubTator, text mining | PubMed |
| LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis. | Cell J | 2022 | 35717565 | PubTator, text mining | PubMed |
| LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications. | J Cancer | 2022 | 35711823 | PubTator, text mining | PubMed |
| Identification of HOX signatures contributing to oral cancer phenotype. | Sci Rep | 2022 | 35710803 | PubTator, text mining | PubMed |
| Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci. | Genes Dev | 2022 | 35710139 | PubTator, text mining | PubMed |
| Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer. | Bioengineered | 2022 | 35706412 | PubTator, text mining | PubMed |
| The minor allele of rs17427875 in long non-coding RNA-HOXA11-AS influences the prognosis of subarachnoid hemorrhage (SAH) via modulating miR-15a and STAT3 expression. | Aging (Albany NY) | 2022 | 35700456 | PubTator, text mining | PubMed |
| Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. | Cancers (Basel) | 2022 | 35681606 | PubTator, text mining | PubMed |
| DNA methylation in pulmonary fibrosis and lung cancer. | Expert Rev Respir Med | 2022 | 35673969 | PubTator, text mining | PubMed |
| Triclosan activates c-Jun/miR-218-1-3p/SLC35C1 signaling to regulate cell viability, migration, invasion and inflammatory response of trophoblast cells in vitro. | BMC Pregnancy Childbirth | 2022 | 35668364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=20